Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms
By: Sarah Medrek and Zeenat Safdar
References
- Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001 Nov 15; 345( 20): 1465– 72.
- Simonneau G, Gatzoulis MA, Adatia I, Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62( 25 Suppl): D34– 41.
- Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013 Feb; 41( 2): 462– 8.
- Schweikert B, Pittrow D, Vizza CD, Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries. BMC Health Serv Res. 2014 Jun 9; 14: 246.
- Delcroix M, Lang I, Pepke-Zaba J, Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. 2016 Mar 1; 133( 9): 859– 71.
- Pepke-Zaba J, Delcroix M, Lang I, Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011 Nov 1; 124( 18): 1973– 81.
- Lang IM. Chronic thromboembolic pulmonary hypertension--not so rare after all. N Engl J Med. 2004 May 27; 350( 22): 2236– 8.
- Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation. 1999 Mar 16; 99( 10): 1325– 30.
- Pengo V, Lensing AW, Prins MH, Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004 May 27; 350( 22): 2257– 64.
- Becattini C, Agnelli G, Pesavento R, Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006 Jul; 130( 1): 172– 5.
- Miniati M, Monti S, Bottai M, Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore). 2006 Sep; 85( 5): 253– 62.
- Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010 Jun; 95( 6): 970– 5.
- Poli D, Grifoni E, Antonucci E, Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism. J Thromb Thrombolysis. 2010 Oct; 30( 3): 294– 9.
- Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y. Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost. 2012 Jun; 18( 3): 281– 8.
- Giuliani L, Piccinino C, D'Armini MA, Prevalence of undiagnosed chronic thromboembolic pulmonary hypertension after pulmonary embolism. Blood Coagul Fibrinolysis. 2014; 25( 7): 649– 53.
- Guerin L, Couturaud F, Parent F, Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost. 2014 Sep 2; 112( 3): 598– 605.
- Yang S, Yang Y, Zhai Z, Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. J Thorac Dis. 2015 Nov; 7( 11): 1927– 38.
- Galiè N, Humbert M, Vachiery JL, 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015 Oct; 46( 4): 903– 75.
- Tapson VF, Platt DM, Xia F, Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM Study. Am J Med. 2016 Sep; 129( 9): 978– 85.
- Peacock A, Simonneau G, Rubin L. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006 Sep; 3( 7): 608– 14.
- Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993 Mar; 103( 3): 685– 92.
- Lang I. Chronic thromboembolic pulmonary hypertension: a distinct disease entity. Eur Respir Rev. 2015 Jun; 24( 136): 246– 52.
- Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation. 1992 Oct; 86( 4): 1241– 8.
-
Morris
TA,
Marsh
JJ,
Chiles
PG,
Auger
WR,
Fedullo
PF,
Woods
VL
Jr. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med. 2006 Jun 1; 173( 11): 1270– 5. - Li JF, Lin Y, Yang YH, Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance. PLoS One. 2013 Jul 22; 8( 7): e69635.
- Zabini D, Heinemann A, Foris V, Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J. 2014 Oct; 44( 4): 951– 62.
- Quarck R, Wynants M, Verbeken E, Meyns B, Delcroix M. Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Eur Respir J. 2015 Aug; 46( 2): 431– 43.
- Waltham M, Burnand KG, Collins M, McGuinness CL, Singh I, Smith A. Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost. 2003 Jan; 89( 1): 169– 76.
- Bonderman D, Jakowitsch J, Redwan B, Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2008 Apr; 28( 4): 678– 84.
- Firth AL, Yao W, Ogawa A, Madani MM, Lin GY, Yuan JX. Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Cell Physiol. 2010 May; 298( 5): C1217– 25.
- Galiè N, Kim NH. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006 Sep; 3( 7): 571– 6.
- Dorfmuller P, Gunther S, Ghigna MR, Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J. 2014 Nov; 44( 5): 1275– 88.
- Jujo T, Sakao S, Ishibashi-Ueda H, Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance. PLoS One. 2015 Aug 7; 10( 8): e0133167.
- Bonderman D, Wilkens H, Wakounig S, Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009 Feb; 33( 2): 325– 31.
- Condliffe R, Kiely DG, Gibbs JS, Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009 Feb; 33( 2): 332– 8.
- Bonderman D, Turecek PL, Jakowitsch J, High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003 Sep; 90( 3): 372– 6.
- Wong CL, Szydlo R, Gibbs S, Laffan M. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis. 2010 Apr; 21( 3): 201– 6.
- Wolf M, Boyer-Neumann C, Parent F, Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000 Feb; 15( 2): 395– 9.
- Kimmig LM, Palevsky HI. Review of the Association between Splenectomy and Chronic Thromboembolic Pulmonary Hypertension. Ann Am Thorac Soc. 2016 Jun; 13( 6): 945– 54.
- Desmarais J, Elliott CG. Familial Chronic Thromboembolic Pulmonary Hypertension. Chest. 2016 Apr; 149( 4): e99– e101.
- Feng YX, Liu D, Sun ML, BMPR2 germline mutation in chronic thromboembolic pulmonary hypertension. Lung. 2014 Aug; 192( 4): 625– 7.
- Xi Q, Liu Z, Zhao Z, Luo Q, Huang Z. High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension. PLoS One. 2016 Jan 28; 11( 1): e0147396.
- Bonderman D, Jakowitsch J, Adlbrecht C, Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2005 Mar; 93( 3): 512– 6.
- Klok FA, Dzikowska-Diduch O, Kostrubiec M, Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J Thromb Haemost. 2016 Jan; 14( 1): 121– 8.
DOI: https://doi.org/10.14797/mdcj-12-4-195 | Journal eISSN: 1947-6108
Language: English
Page range: 195 - 198
Published on: Oct 1, 2016
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2016 Sarah Medrek, Zeenat Safdar, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.